
Stephen Bentley Williams MD MBA, MS, FACS, FACHE
Surgical Oncology
Associate Chief Medical Officer UTMB Clear Lake, Medical Director of High Value Care UTMB Health System, Professor Tenured and Chief of Urology, Robert Earl Cone Professorship, Director of Urologic Oncology, Director of Urologic Research
Join to View Full Profile
The University of Texas Medical Branch - John Sealy Hospital301 University BlvdGalveston, TX 77550
Phone+1 409-772-2091
Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2014 - 2016
- Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 2007 - 2011
- Mass General Brigham/Brigham and Women's HospitalResidency, Surgery, 2006 - 2007
- George Washington University School of Medicine and Health SciencesClass of 2006
Certifications & Licensure
- CA State Medical License 2011 - 2027
- TX State Medical License 2014 - 2025
- MA State Medical License 2008 - 2013
- American Board of Urology Urology
Publications & Presentations
PubMed
- Real-World Economic Burden and Healthcare Resource Utilization of Radical Cystectomy and Trimodal Therapy for Bladder Cancer in the United States.Stephen B Williams, Halit O Yapici, Puneet K Singhal, Ian Weimer, Farah Pathan
Urology. 2025-03-21 - 1 citationsPredicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: D...Yair Lotan, Viswesh Krishna, Waleed M Abuzeid, Bryn Launer, Sam S Chang
The Journal of Urology. 2025-02-01 - Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer.Siamak Daneshmand, Ashish M Kamat, Neal D Shore, Joshua J Meeks, Matthew D Galsky
Urologic Oncology. 2025-01-15
Journal Articles
- Seminars Article New Horizons in Bladder Cancer ResearchStephen B Williams, Ashish M Kamat, ScienceDirect
- Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer—ReplyAshish M Kamat, Stephen B Williams, JAMA
- Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and UrologistsChristopher J Weight, Stephen B Williams, James B Yu, Jon C Tilburt, Simon P Kim, Badrinath Konety, Annals of Surgical Oncology
- Join now to see all
Press Mentions
- New Study Links Texas Oil Refineries to Elevated Cancer RiskDecember 1st, 2020
- Efforts to Prevent Further Resurgence of COVID-19, an Update from Galveston, Texas - Stephen WilliamsJuly 25th, 2020
- COVID-19: A View Within the Pandemic Inside the Healthcare System and Bladder Cancer Care - Stephen WilliamsApril 3rd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: